Cite Filings / SYRE / 0001636282-24-000021

Feed Companies Filings Check

Sign in

DEF 14A

Proxy Statement

Spyre Therapeutics, Inc. Filed 2024-04-01 Acc 0001636282-24-000021

Documents 1

DEF 14A Proxy Statement , syre-20240401.htm

Around this filing

2025-04-14 DEF 14A Proxy Statement
2024-04-02 SEC STAFF LETTER SEC Staff Letter Redacted Exhibit
2024-04-02 ARS Annual Report to Security Holders
2024-04-01 EFFECT Notice of Effectiveness
2024-04-01 EFFECT Notice of Effectiveness
2024-04-01 DEF 14A Proxy Statement
2023-10-27 DEF 14A Proxy Statement

Link to a passage

Paste a passage to link it

At least 12 characters, not counting spaces, so the link points to one passage.

External

SEC EDGAR (opens in new tab)
SEC Structured Data (opens in new tab)

Loading syre-20240401.htm…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…